- ... OR “Opioid Abuse*” OR “Opioid Misuse” OR “Opioid Addiction” OR “Opioid*” OR “Prescription Drug Misuse” OR “Prescription ... OR “Opioid Abuse*” OR “Opioid Misuse” OR “Opioid Addiction” OR “Opioid*” OR “Prescription Drug Misuse” OR “Prescription ...
- ... American light smokers: a 2 × 2 factorial design. Addiction. 2006 Jun;101(6):883–91. doi: 10. ... and Hispanic/Latino communities: conceptual and systemic considerations. Addiction. 2007 Oct;102 Suppl 2:112–22. PMID: ...
- ... N. RNA-binding proteins, neural development and the addictions. Genes Brain Behav. 2016 Jan;15(1):169– ... with the motor system in autism and drug addiction. Cogn Affect Behav Neurosci. 2016 Apr;16(2): ...
- ... N. RNA-binding proteins, neural development and the addictions. Genes Brain Behav. 2016 Jan;15(1):169– ... with the motor system in autism and drug addiction. Cogn Affect Behav Neurosci. 2016 Apr;16(2): ...
- ... Cannabis: pharmacology and toxicology in animals and humans. Addiction 91 (11): 1585-614, 1996. [ PubMed : 8972919 ] Abrams ... Cannabis: pharmacology and toxicology in animals and humans. Addiction 91 (11): 1585-614, 1996. [ PubMed : 8972919 ] Grotenhermen ...
- ... between use of prescription opioids and risk of addiction, 22 overdose, 22 fractures, 23 – 25 falls 24 , ... higher doses of opioids and risks of overdose, addiction, and endocrinological adverse events; 22 , 23 , 26 – 29 ...
- ... exp substance-related disorders/ 61 use mesz, prem addiction/ or exp drug abuse/ or drug overdoses/ or ... related disorders/ 72 71 use mesz, prem 73 addiction/ or exp drug abuse/ or drug overdoses/ or ...
- ... in an integrated health care system. Journal of Addiction Medicine. 2017;11(1):3–9 [ PMC free ... Waiting Lists Grow for Medicine to Fight Opioid Addiction. Pew Charitable Trusts. February 11, 2016. www .pewtrusts. ...
- ... near-term suicide risk, among other recommendations. Suicide Prevention Treatment Although the studies of treatment to prevent ... narrow slice of the larger body of suicide prevention intervention trials. Given the need for safety among ...
- ... Hoffmann et al 2003 , Zafeiriou et al 2009 ]. Prevention of Primary Manifestations As described in Treatment of ... and biallelic TH pathogenic variants have been reported. Prevention of Secondary Complications Additional side effects associated with ...